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Introduction 
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Survival is a function of the ability of an 
organism to fill its ecological niche efficiently and 
to defend itself against aggression. The evolution 
from unicellular through ollgocellular to multicellular 
forms with highly differentiated organ systems involves 
many obvious advantages. But there are also disadvant¬ 
ages. Multicellular organisms may be hosts for uni¬ 
cellular and subcellular pathogens; moreover, the 
processes of rapid proliferation and extensive different¬ 
iation create increased opportunities for somatic 
mutation and the development of uncontrolled neoplastic 
cell lines. It is teleologically reasonable, albeit 
unproven, that defenses should develop to meet these 
challenges. 
In 1882 Metchnikoff proposed that phagocytic 
cells provided significant protection against microbial 
infections. He showed that phagocytosis is an important 
defense in a wide range of species -- from amoeba and 
colonial protozoa where phagocytic and digestive functions 
are combined, through higher forms in which wandering 
cells can be mobilized for use in any part of the 
organism (Humphrey & White, 1970). Metchnikoff's theory 
was strongly attacked by those who stressed the contri¬ 
bution of specific humoral defense factors. For many 
reasons, including methodological difficulties, specific 
cell-mediated defenses were only slowly appreciated. In 

1891 Koch described the delayed time course of a skin 
reaction * elicited by an intradermal tuberculin test 
in a sensitized host. In following years the perivascular 
mononuclear cell infiltrate characteristic of these 
lesions was noted (reviewed by Uhr, 1966). Landsteiner 
in 19^2 showed that while serum alone could not transfer 
the ability to produce a delayed skin test, peritoneal 
exudate cell could. Further work by Chase and others 
established that lymphoid cells were the necessary and 
effective component of such an "adoptive transfer" 
(Bloom & Chase, 196?). Landsteiner also developed 
"artificial antigens" — well-defined small molecules 
(haptens) attached to proteins (carriers). Using 
these he demonstrated that humoral antibody of marked 
hapten specificity could be elicited (Landsteiner, 19^5)* 
In contrast, delayed hypersensitivity was shown to 
display carrier specificity (Benacerraf & Gell, 1959). 
These four characteristics — the delayed time 
course and the histology of the in vivo reaction, 
transferability by living lymphoid cells but not by 
serum, and carrier specificity -- have remained the 
basic criteria for defining delayed hypersensitivity. 
Classical tubercular hypersensitivity and contact allergy 
are now considered two examples of cell-mediated 
immunological reactions; others include immunity to 
intracellular parasites, homograft rejection and 
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tumor rejection. The operative cells belong to a sub¬ 
population of lymphocytes dependent on the presence of 
the thymus and referred to as T-lymphocytes. The other 
functionally defined population of cells is called 
B-lymphocytes. These differentiate, proliferate and 
mature into plasma cells which synthesize humoral 
antibody. 
Specifically sensitized T cells are directly 
cytotoxic for target cells and when exposed to antigen, 
they release soluble factors which effect vascular 
permeability, macrophage activity and other lymphocytes 
(Roitt, 1969). These responses seem to be the mechanism 
for the observed in vivo phenomena and have become the 
basis for a host of in vitro assays. In addition, T cells 
may cooperate with precursors of antibody-producing cells 
during the immune response to certain antigens ("helper" 
cell function). 
In clinical and experimental situations where 
the thymus is congenitally absent, there is a defect 
in the ability of the organism to mount an immune response. 
Homografts are not rejected, contact sensitization 
cannot be achieved and humoral antibody reponse to a 
variety of protein antigens is diminished. Patients with 
such defects are highly vulnerable to opportunistic viral 
and fungal infections and the natural history of the 
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disease is brief and fatal. Clinically and immune- 
logically, depletion of cell-mediated immunity (CMI) is 
a much graver defect than absence of humoral antibody 
(Fudenberg et al» 1971). The class of lymphocytes 
associated with CMI, the T cells, seem intimately 
related to the capacity for organizing an immune response, 
particularly to proteins, which are apparently the most 
relevant naturally-occurring antigens. 
The clonal selection theory of immunology 
postulates that immunocompetent lymphocytes are pre¬ 
committed to respond to specific antigens. It seems likely 
that the initiation of cellular activity for an immune 
response is mediated by the interaction of antigen with 
specific cellular receptors. However, the receptors 
for T-lymphocytes are only poorly characterized in 
structural or functional terms. 
One approach to the study of T-cell receptors 
is through affinity labelling, a technique which has 
been very useful in the study of antibody combining 
sites (Singer, 196?). The method depends upon the 
ability of a bifunctional reagent to (1) combine 
specifically with the particular antibody, and (2) react 
readily with amino acid residues to form covalent bonds. 
Hill (1971) reported that a hapten-derived affinity label 
could interfere with T-cell function and could permit 
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the isolation of a putative receptor. The first part of 
this study is an attempt to reproduce that system. 
Whereas humoral antibody can be hapten specific, 
cellular immunity consistently shows "carrier specificity". 
It would be useful to have a system which would 
facilitate more careful investigation of this requirement 
of T-cell function. The relevant "carrier" determinants 
of classical hapten-protein antigens cannot be precisely 
identified. A defined sequence polypeptide antigen, 
however, could be used to study the specificity of the 
cell receptor and the requirements for immunogenicity. 
Further, such an antigen could serve as the basis of 
a "carrier-derived" affinity label. Thus, the second 
part of this study involved the synthesis of a defined 
sequence polypeptide antigen. 

Materials, Methods and Results 
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I. Efforts to Synthesize a Hapten-Derived Affinity Label 
(after Hill, 1971) 
Materials. 
6-2,4-dinitrophenyl-L-lysine (DWP-lysine) was a 
gift of Dr. William Konigsberg (prepared by the method 
of Porter, 1950). Na2S was stored at 4°C. The "reducing 
solution" was: Na2S*9H20 (4.8g, 2Qmmol) plus NaHCOo 
(1.68g, 20mmol) in H20 (10ml) at 40° C (after Hodgson 
& Ward, 1945). 
Reduction of DNP-lysine (after Hodgson & Ward, 1945)* 
£-DNP-L-lysine HC1 (348.5mg» Immol) (I in Fig. 1) 
was dissolved in methanol (10ml), neutralized by drop- 
wise addition of ION NaOH, and warmed to 55°0. The 
reducing solution was added dropwise until in excess 
as detected by ferrous sulfate paper. The solution was 
then cooled to 0° and the precipitate filtered and 
recrystallized from ethanol. The clean tan crystals 
were shown to have one nitro group reduced to an amino 
group (see below). Which group was reduced is unclear, 
but could probably be established by NMR studies. The 
product is called £-2,4-(nitro, amino) phenyl-L-lysine 
(NAP-lysine) (II). 
I? 
Figure 1 
Dinitrophenyl Derivatives 
I DNFB 
F 
1-fluoro-2,4-dinitrobenzene 
II £-DNP-lysine £-2,4-dinitrophenyl-lysine 
III m-NBDF m-nitrobenzenediazonium 
fluoroborate 
IV £-NAP-lysine £-2-nitro-4-aminopheny1-lysine 
fJH 
HLfO-CH-CO0 H 
£-2-nitro-4-diazophenyl-lysine V £-NDP-lysine 
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Evidence for Formation of NAP-lysine. 
(1) Electrophoresis. (Conditions given and results 
diagrammed in Fig. 2). The results indicate the presence 
of an additional positively charged group on NAP-lysine. 
(2) Formation of a colored azo dye. NAP-lysine 
(approx 5rog) in was chilled in an ice-bath 
and concentrated (3-4 drops) added. Chilled 1% 
NaNOj solution was then added dropwise until in excess 
as indicated by starch-KI paper. Dropwise addition of 
this solution to 2-napthol in 10# NaOH yielded formation 
of a red-brown precipitate. This is presumed to be an 
azo dye, thus implying the presence of a diazotizable 
amino group on the starting material. Negative controls 
included (1) starting with DNP-lysine and (2) omitting 
NaNO^ solution. 
(3) Mass spectroscopy. The molecular weight of the product 
was not successfully established due to technical 
difficulties. 
Binding of NAP-lysine to anti-DNP antibody. 
Anti-DNP antibody was isolated from rabbit immune 
sera (approx Img Ab/ml) by the method of Eisen (1964a). 
Two stock solutions of antibody in 0.1M Tris (pH?.6) 
were prepared: (a) 0.480mg/ml) for use in equilibrium 
dialysis and (b) 0,04?mg/ml for use in fluorescence 
quenching. 

Figure 2 
Electrophoresis of NAP-lysine 
or i g 
o 
T” 1 l 1 
! A 1 
O ! 6 1 
0 o o 
1 1 
I c 
1 1 1 X_ — — - _ ___ - - - — - _ - 
Conditions* pH 2.3. buffer, formic acid j glacial acetic 
acid j water :: 3»3®1 of 98% soln : 29^1 : 2000ml; 
voltage, constant at 250v; amperage, approx. 
?mamp; time, 90min. 
Notation: A = DNP-lysine (starting material) 
B = NAP-lysine (recrystallized) 
C = crude reaction mixture 
Results and Interpretation. 
The product, NAP-lysine (B), contains more 
positive charge than the starting material, DNP-lysine (A). 
If the difference in movement is interpreted as linearly 
proportional to charge, then B has twice as many positive 
charges. That is, B has two positive charges to A's one. 
We presume that the additional positive charge results 

Figure 2 (continued) 
from the reduction of a nitro group to an amino group. 
The crude reaction mixture (C) contains not only 
(A) and (B) but also an additional side product which 
moves further toward the cathode. This has an even 
greater positive charge and presumably represents 
the doubly reduced diaminophenyl compound. 
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Equilibrium dialysis (Eisen, 1964b) was performed 
with micro-dialysis cells (Gateway Immunoserum Co., 
Illinois). £-2,4-DNP-L-lysine (New England Nuclear 
Co., Mass.) of specific radioactivity 2.57 x lO^^cpm/mole 
was a gift of Dr. R.W. Rosenstein. With this a stock 
solution of 1 x 10“6m ^H-DNP-lysine in Tris buffer was 
prepared. The dialysis cells used 50jul on each side of 
the membrane. One side received 5Q**1 of antibody stock 
solution. When evaluating the antibody, the other side 
received 5»10»15»25 or 50nl of hapten solution plus 
(50-x)nl of buffer. When evaluating inhibition by 
£-NAP-L-lysine» this side received 10;ul (or 151*1) of 
— ^ -4 
DNP-lysine solution plus 40nl (or 35mD of 10 J% 10 , 
lO”^ or 10“^M NAP-lysine solution. The cells were 
equilibrated overnight and then 25**1 of each side was 
counted on a scintillation counter. 
The results of these three determinants showed 
that the antibody preparation had a K0 of about 
3.0 x 106 (M/L)”1 and an r of about 1.1, NAP-lysine, 
even at over 1,000-fold excess, did not interfere with 
DNP-lysine binding. 
Fluorescence quenching was done by the method of 
Eisen (1964c). The stock solution of DNP-lysine used 
was 1 x 10"^M. The 3®1 cell was filled with an antibody 
solution and the hapten solution added in 10.nl increments. 
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The results of two determinations give a K0and r for the 
antibody preparation in the same range as that noted 
above. 
The following experiments were performed using 
an NAP-lysine solution of 1 x 10"°2M. (1) NAP-lysine, 
in I0;ul increments up to lOCyul total, produced only a 
slow linear non-specific quenching of fluorescence, not 
the sharp initial drop indicative of specific binding. 
When DNP-lysine was then added, a classic quenching 
curve was obtained. The K0and r calculated from this 
curve were remarkably consistent with previous results, 
despite the presence of 100-fold excess of NAP-lysine. 
(2) NAP-lysine and DNP-lysine aliquots were added 
alternately to the antibody solution. Quenching was 
observed only when DNP-lysine was added. There was no 
increase or decrease in fluorescence when NAP-lysine was 
added. Thus DNP-lysine caused normal fluorescence 
quenching despite the presence of 100-fold excess of 
NAP-lysine. 
In summary, there was no evidence that €-NAP-lysine 
could bind to anti-DNP antibody. Affinity labelling 
of antibody or immune cells with the diazo-derivative 
was not attempted. 
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II. Preparation of a Synthetic Polypeptide Antigen 
Materials. 
C-DNP-L-lysine HC1 was obtained as above. 
NCA-L-t.yrosine and NCA-D,L-alanine (Pilot Chemical Co., 
Watertown, Mass.) were stored in a vacuum desiccator 
at -20°C, Absolute ethyl alcohol , reagent grade, and 
dry HC1 gas (Matheson Co Inc., New Jersey) were used in 
the synthesis of £-LNP-L-lysine ethyl ester HC1. Gel 
chromatography was performed with Sephadex G-25 and 
G-50 (Pharmacia Fine Chemicals, Sweden) and Bio-Gel P-2 
(Bio-Rad Laboratories, Calf.). 
Rationale and Principles of the Method of Synthesis. 
For reasons that will be elaborated in the 
discussion, the antigen desired for this study was: 
(D-ala-L-ala-L-ala-L-tyr-B-ala-L-ala-D-ala-L-tyr- 
D-ala-L-ala-D-ala-G-DNP-L-lys)^ q 
The procedure of choice for synthesizing the monomeric 
subunit is the Merrifield solid-state method (Merrifield, 
1969). However, this method is very time-consuming. 
An alternative procedure involves the use of 
N-carboxy-oc-amino acid anhydrides (NCAs) (Katchalski 
& Sela, 1958). These amino acid derivatives have been 
employed extensively to make synthetic polypeptides for 
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immunological studies (Sela, 1966; Sela, 1969)* The 
polymerization of NCAs in inert solvents (e.g. dioxane) 
may be initiated by primary amines (e.g® amino acid esters 
or peptides). Polymerization under these conditions 
may be described by an initiation reaction (Fig. 3a) 
and a propagation reaction (Fig. Jb), 
The occurrence of the initiation reaction formul¬ 
ated has been demonstrated by the disappearance of the 
initiator from the reaction mixture and the simultaneous 
appearance of the corresponding amino acid amide during 
the early stages of polymerization. The latter contains 
a free ot-amino group and may, therefore, continue to 
react with available NCA. Dimers, trimers and higher 
peptides are formed by successive propagation steps 
and grow continuously until the reaction ceases because 
of either exhaustion of the NCAs or the disappearance 
of the terminal amino groups by a termination reaction 
(i.e. side reactions which diminish the number of free 
tf-amino groups in the system). The occurrence of a 
propagation reaction of the type given above is supported 
by the observation that the polymerization of different 
NCAs can be initiated by peptides and by preformed 
polyamino acids containing free ot-amino groups. Further¬ 
more, no change in the concentration of free amino groups 
occurs in the polymerization devoid of a termination 
reaction. 

Figure 3 
Description of NCA Reactions 
(a) Initiation. 
R, R^H + 
pH-Co / 
£ 
(b) Propagation. 
A £ 
— I '—| } 
K, £-y (\J- \CO-ClH~ A/ . -CO-CH-fiJH-i. 
L —1 j-1 
tl-cP-co N 
-p ' / 
pH-CO 
P 
£ £ 
/OhJ.-CO-CH-PH^ 
\J 
+ c°z. 
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In the polymerization scheme proposed above, 
growing chains react only with free NCAs and not with 
each other. Therefore in the absence of a termination 
reaction, which may usually be neglected at room temp¬ 
erature, a narrow Poissonian molecular weight distribution 
may be expected. Thus, the peptides formed would be 
predicted to have a length determined by the starting 
ratio of NCAs to initiator, and a composition reflecting 
the original mixture of NCAs, The sequence of amino acid 
residues is uncontrolled and should be, to a considerable 
degree, random (Katchalski & Sela, 1958), Thus, using 
the NCA procedure, a model compound could be synthesized 
more easily than the ideal one, though it would be 
less well defined. 
The task was to synthesize a peptide approximating 
(D,L-ala10,L-tyr2)-£-DNP-L-lys 
by using £-DNP-L-lysine as an initiator of an appropriate 
mixture of D,L-ala-NCA and L-tyr-NCA. The most satisfactory 
procedure was to synthesize the ethyl ester of 
6-DNP-L-lysine HC1, neutralize it, and use the ethyl 
ester free base as the initiator. An example of this 
procedure is detailed below? for other systems and further 
details, see Appendix. 
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Synthesis of the Initiator. 
£-DNP-L-lysine HC1 (200mg» Q,57nunol) was suspended 
in ethanol (4ml) and a stream of HC1 gas passed through 
rapidly, without external cooling. After the amino acid 
dissolved, the hot reaction mixture was cooled in an 
ice bath, and the introduction of gas continued to 
saturation (approx, 2 hours). The reaction mixture was 
then sealed and let stand in a desiccator overnight at 
room temperature. By the next day the reaction had 
gone virtually 100% as determined by silica gel thin 
layer chromatography (Buffer -- butanol: acetic acid: 
water: pyridine::15:3s12:10). Dry nitrogen gas was 
passed through to drive off much of the excess HC1 and 
then the solution was dried in vacuuo over sodium 
hydroxide. The yellow residue was recrystallized from 
ethanol and ether and dried in vacuuo again. The yield 
of £-DNP-L-lysine ethyl ester HC1 was approximately 90% 
(193mg, O.513nimol) (Greenstein & Winitz, 1961). 
This product (105mg, 0.30mmol) was dissolved 
in 50% ethanol (4ml), neutralized with Na2CC>3 (0.15mmol) 
and dried in vacuuo, leaving a residue of £-DNP-L-lysine 
ethyl ester free base plus an equimolar amount of NaCl. 
The residue was not soluble in dioxane or THF, either 
separately or mixed. It was largely soluble in benzene- 
dioxane (3•0ml,plus 0.5ml), although a noticeable 
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amount of yellow, almost syrup-like flocculate was 
present. This mixture was used to initiate the poly¬ 
merization reaction. 
Synthesis and Isolation of a Peptide (SAM-4). 
NCA-D,L-alanine (484mg, 4.2mmol) and 
NCA-L-tyrosine (186mg, 0,9mmol) were dissolved in 
dioxane (3•0 - 4.0ml). The NCAs dissolve completely 
in dioxane; a cloudy solution indicates some 
decomposition to free amino acid. The NCA solution 
and initiator solution were mixed and stirred overnight 
at room temperature. The next day an equal volume (?ml) 
of IN NaOH was added. The solution now became clear 
and was stirred another two hours. These conditions 
had been shown, using silica gel thin layer chromat¬ 
ography, to completely de-estrify £-DNP-L-lysine ethyl 
ester. After two hours the solution was neutralized 
(6N HC1) and lypholyzed. 
Aliquots (lOOmg) of the lypholyzed powder were 
dissolved in sodium phosphate buffer (0.01M, pH7.4; 4ml). 
Insoluble material was separated by centrifugation and 
the supernatant chromatographed on G-25 Sephadex (Fig. 4). 
The OD^q an<* °^2?8 ^racti°ns were 
measured. The former is the E for 6-DNP-L-lysine 
max 
(£=17>400); the latter is influenced strongly by 
■' 
Figure 4 
SAM-4; Gel Chromatography Fractionation 
OD^q and OD^g vs_ Tube number 
Conditions: G-25 Sephadex column (2.8cm x 55cm) eluted 
with PBS (Phosphate Buffered Saline: 0.01M 
Phosphate, pH7.4, 0.155^ NaCl). Each tube 
represents 4.9min collection (approximately 
5ml). 
Results: By spectroscopic analysis. 
Peak (Tubes) Average Composition 
(B,L-ala:L-tyr: -DNP-L-lys) 
SAM-4A (32-62) 14 : 3 : 1 
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the DNP group (€=3*000), but is also the isosbestic point 
for tyrosine (£=1,350) (Greenstein & Winitz* 196l). A 
graph of both OD's against fraction number provides an 
impression of the variation in the relative amount of 
tyrosine per DNP group throughout the gel separation. 
That is, if the two curves are parallel, a peak is 
more likely to represent a homogeneous population of 
peptides of relatively constant tyrosine:DNP content 
(e.g. SAM-4, Fig. 4); if the two curves are not parallel, 
there are likely to be several overlapping populations 
of peptides of different composition (e.g. SAM-3, see 
Appendix). Fractions were pooled, lypholyzed, desalted 
on a Bio-Gel P-2 column, and lypholyzed again. The 
product was then either polymerized or used directly for 
immunization. 
A more precise determination of the average 
amino acid composition of an isolated peak was made 
by either amino acid analysis or spectrophotometry. For 
the former, a small aliquot was dissolved in 6n (constant 
boiling) HC1, sealed under vacuum in an ampule, heated 
to 110°C for 16 hours, dried in vacuuo and dissolved 
in analyzer buffer (0.01N HC1). The £-DNP-L-lysine 
content of an aliquot was determined from the OD^q and 
the alanine and tyrosine content from the amino acid 
analyzer. For the spectrophotometric method, an aliquot 
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of peptide was diluted in 0.1N NaOH. The 
£-DNP-L-lysine content was determined from the OD^q 
Umax» £=17*^00), and the tyrosine content from 
OD0oo - (A , 6=2,330) after correction for the DNP 
contribution (ODg^ ^/OD^q = 0.170). The alanine content 
was estimated by assuming an alaninejtyrosine ratio 
equal to that of the Initial reaction mixture. 
Synthesis of the Polymer. 
The pentachlorophenyl active ester polymerization 
method was used (Kovacs et al, 1966; Richards et al, 196?). 
The peptide monomer (SAM-4A, 15umol) was dissolved in a 
minimum volume of dichloroethanol (0.3ml) and a 1,1 molar 
excess of pentachlorophenol added. The mixture was 
cooled to 0 C and a 1.1 molar excess of triethylamine 
and N.N’-dicyclohexylcarbodiimide added. It was then 
shaken intermittently at 0°C for 12 hours, and dried in 
vacuuo at 36 C. Unfortunately, chromatography on 
Sephadex G-50 and G-25 gave no evidence of polymerization. 
There was insufficient time to perform quantitative 
dansylation and Edman degradation. This procedure would 
determine the number of N-terminal amines available per 
DNP group and thus the degree of polymerization. The 
inability to polymerize the peptide is probably a 
result of the low concentration of the reaction solution. 
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Both reports cited above required 1M concentrations of 
monomer to achieve polymerization. Because of low 
yields, only 0.05M monomer was present in our reaction 
mixture. 
Immunization and Challenge. 
Four to six male and female Hartley strain guinea 
pigs, weighing 350 - 400g, were used for each peptide 
tested. Suitable dilutions of peptides (50Qmg/ml) were 
emulsified with an equal volume of complete Freund’s 
adjuvant (Difco Labs, Inc., Michigan). Each animal 
received lOOmg of peptide distributed in the four foot 
pads in a volume of 0.1ml per foot pad. Eight days later, 
the guinea pigs were skin tested intradermally in one 
flank with lOmg of peptide in 0.1ml of isotonic 
saline and in the other flank with lOmg of PPL. On 
day 10, they were challenged with 50mg of peptide, 
Non-immunized control pigs were similarly challenged 
with peptide. Reactions were read at 4hr and 24hr 
following challenge. Two perpendicular diameters of the 
reaction site were measured and averaged. 
No immediate reactions were seen. All immunized 
guinea pigs reacted to PPD with more than 10 x 10mm 
of erythema and induration, most with more than 14 x 14. 
No immunized pigs had more than 4 x 4mm of erythema and 
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induration to any peptide tested. A similar amount of 
reaction was seen in the control pigs. Biopsies of 
the challenge site of two immunized pigs revealed only 
non-specific polymorphonuclear leukocyte infiltrate 
with no mononuclear cells or perivascular cuffing. A 
list of the peptides used for immunization, their code 
and their composition is given in Table I. 

Table I. 
Peptides Tested for Innnunogenicity 
Code Name Average Composition Approximate 
(D,L-ala:L-tyr: -DNP-L-lysine) Molecular Weight 
SAM-2E 
SAM-3A 
SAM-4A 
SAM-4A-P* 
10.8 : 2.3 t 1 
18.2 ; 4.0 : 1 
14.0 : 3.0 : 1 
(14.0 : 3.0 : l)?n 
1200 
2100 
1600 
(l600)x(?n) 
* 
The products of the polymerization procedure were 
tested despite lack of evidence that polymerization 
was actually achieved. 

Discussion 
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Receptors: Some general considerations. 
Central to the clonal selection theory of the 
immune response is the process by which the immune- 
logically competent, precommitted cell can recognize -~ 
and thus be selected by — specific antigenic determinants. 
Such a process must involve structures which interact 
with antigens with sufficient energy — bind with 
sufficient affinity -- to initiate the cellular activities 
that are the immune response. These "recognition 
structures" are clearly crucial to the specificity and 
control of the immune system (Siskind & Benacerraf, 1969)• 
They are referred to as "antigen-binding receptors". 
In broad functional terms, a receptor is the 
mechanism by which a signal is perceived and a response 
initiated; it is the process which mediates the afferent 
interactions between a "black box" and its environment. 
In many biological systems, such as the immune response, 
this function may take the following structural form. 
The signal is a small molecule or a particular confor¬ 
mational determinant of a macromolecule. The signal¬ 
binding or recognition site is most likely to be a 
cleft or area of a macromolecule. The initial interaction, 
the "specific" binding of one molecule by another, may 
occur either outside the cell, at the surface membrane, 
or inside the cell. The interaction yields a bimolecular 
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complex of "higher informational content" which may 
directly stimulate the cell in a variety of ways, for 
example, by derepressing a gene, by activating an 
enzyme, or by serving as an enzyme substrate. Alternatively, 
these mechanisms may produce a second intracellular 
signal necessary to initiate the cell response. Thus, 
the receptor function may be structurally very complex. 
Nevertheless, two components can be differentiated -- 
(1) the specific binding of the signal and (2) the 
mechanism by which that binding leads to cell activation. 
The processes relevant to the non-covalent binding of 
two molecules have been carefully studied, for example, 
in enzyme-substrate systems, and it is generally assumed 
that similar forces operate in signal-receptor systems. 
However, somewhat greater methodological difficulties are 
involved in elucidating the mechanisms and consequences 
of molecule-cell interaction. This is particularly true 
in systems such as the immune response, where the 
binding structure is believed to function at, and perhaps 
be incorporated into, the surface membrane of the cell. 
In no such systems has the mechanism of receptor function 
been clearly established. 
This discussion will start with a consideration 
of humoral antibody, for which there is more knowledge 
about the relation between the structure and function of 
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the combining site. Next, the focus will be on the 
specificity of cell-mediated immunity, which is a 
functional property of cell binding of antigen, and 
then on structural and mechanistic aspects of the 
recognition site. In this context, affinity labelling 
and synthetic antigens will be considered as techniques 
for studying both functional and structural characteristics 
of the cell receptor in delayed hypersensitivity. 
The Antibody Response. 
Immunization with a classical hapten-protein 
conjugate elicits an antibody population which is 
tremendously heterogeneous both structurally and 
functionally (Haber, 1967; Rockey et al, 1970), A 
sub-population with specificity for the hapten can be 
demonstrated, and the average hapten affinity of 
this fraction increases progressively with time after 
immunization (Risen & Siskind, 1964). This maturation 
phenomenon has been observed in two species with several 
different haptens (Haber et al, 1967). There is evidence 
both from immunological studies (Rabat, 1966; Haber 
et al, 1967) and from X-ray crystallography (Poljak 
et al, 1972), that the antibody combining site is 
approximately 25-44A x 10-17A x 6-10A. This is a 
considerably larger volume than is occupied by a simple 
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hapten such as 6-DNP-lysine (Richards et al, 196?). 
Several studies indicate that determinants near the 
hapten are important in antibody binding, and that immune 
serum may also show maturation against the larger areas 
containing hapten and neighboring determinants (Parker 
et al, 1966; Henney, 1970)® Thus9 there can be an 
antibody population which is specific for regions 
containing both hapten and protein carrier determinants 
and which can bind either hapten alone or protein alone. 
Strausbach et al (1972) have shown such antibodies 
to be physiologically significant. They demonstrated 
that in both in vivo and in vitro systems previously 
sensitized to hapten-carrier conjugates, carrier alone 
could elicit a "signifleant and strong" anti-hapten 
secondary response. The affinities of antibodies 
produced with stimulation either by hapten-carrier 
conjugates or by carrier alone, were comparable; however, 
the antibodies produced by carrier stimulation appeared 
to be slightly more heterogeneous in regard to hapten 
binding specificity. 
However, several important classes of immunogens 
elicit antibody with no maturation of binding affinity 
and with markedly reduced structural heterogeneity. One 
class includes antigens composed of small, strong, 
immunodominant determinant located in the midst of a 
relatively featureless background of rather low 
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immunogenicity» For example, the defined sequence polymer 
of widely spaced £-BNP-lysine residues on a D-L,alanine 
backbone (Richards et al, 1967; Richards et al, 1969) 
elicited antibody whose affinity for 6-DNP-lysine was 
initially high (KA lO^-lO^0) and remained high, and 
which demonstrated restricted heterogeneity throughout. 
One interpretation is that the bland poly-alanine back¬ 
bone apparently contributes minimally to the interaction 
with, and therefore selection of, antibody. Thus the 
antigen elicits only antibody which can bind very 
tightly to the sole available immunogenic determinant -- 
the £-DNP-lysine "hapten”. 
Antibody responses of limited heterogeneity are 
also evoked by large, rigidly structured antigenic 
determinants of nearly sufficient size to fill an anti¬ 
body combining site. Multiple examples of this have now 
been reported (approximate volumes of the antigen are given 
O 
where possible); bradykinin (sphere, diameter 16a) 
(Haber et al, 1967); vasopressin (19A x 14a x 11A) 
(Wu & Rockey, 1969) ? folic acid (Rubenstein & Little, 1970); 
the "loop"-peptide of lysozyme (Maron et al, 1971); and 
(DNP)p-gramicidin-S (Montgomery et al, 1972). The last 
two examples bear closer examination. The "loop"-peptide 
of lysozyme is a sequence of 24 amino acids, located 
on the outer surface of the intact enzyme. It contains 
one intrachain disulfide bond which presumably gives it 
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a relatively constrained configuration. Antibodies 
specific toward this region were prepared (1) by isol¬ 
ation from anti-lysozyme antisera with an immunoadsorbent 
containing loop-peptide or (2) by isolation on a lysozyme 
immunoadsorbent from anti-sera elicited by the loop- 
peptide conjugated to a non-immunogenic synthetic 
polypeptide. Antibodies to the loop region, prepared by 
these methods, showed restricted heterogeneity as 
compared to the totality of anti-lysozyme antibody 
population. Finally, unfolding of the peptide chain 
of the loop-peptide by various methods, resulted in a 
drastic decrease in the reactivity with specific anti¬ 
bodies. This study provides reassurance that the normal 
response to natural protein antigens includes sub¬ 
populations of antibodies directed against structured 
site-filling determinants, and that these sub-populations 
show restrictions of heterogeneity comparable to that 
found in the experimental situations cited. 
(DNP)^-gramicidin-S possesses a rigid, stable, 
cyclic structure with a 2-fold axis of symmetry, carrying 
two DNP groups in an identical conformational environment. 
It is complementary in size to the antibody combining 
site. Rabbits immunized with this antigen produced 
antl-DNP antibody of markedly restricted hetergeneity. 
One closely studied antiserum displayed a "monoclonal 
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isoelectric spectrum and a heterogeneity index of one" 
and was considered "biosynthetically homogeneous" 
(Montgomery et al, 1972), Thus a sufficiently structured 
antigen can apparently select and stimulate a single 
antibody-producing cell clone in vivo. 
In summary, these studies support the following 
conceptualization of the humoral antibody immune response. 
First, although an antibody population may appear to be 
quite specific for a single small determinant (hapten), 
of a larger antigen (hapten-carrier conjugate), significant 
sub-populations may also have considerable interaction 
with adjacent determinants '(i.e. on the carrier). These 
interactions may be crucial to the "classic" character¬ 
istics of an anti-hapten antibody response — the 
heterogeneity of the antibody population and the 
maturation of its binding affinity. Larger, site-filling 
determinants elicit a restricted sub-population of 
antibodies with relatively high, uniform affinity. This 
effect is increasingly pronounced for determinants of 
greater conformational rigidity. 
Functional aspects of the receptors the specificity of 
cell-mediated immunity. 
In contrast to the antibody response, the 
specificity of cell-mediated immunity is poorly charact¬ 
erized. This gap is largely a function of methodological 
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limitations® The product of B cells can be purified 
from serum by a variety of procedures and studied and 
manipulated with a wide range of techniques derived from 
protein chemistry. T cells generally must be obtained 
from lymphoid tissue or peritoneal exudates and require 
careful handling to survive. The purification of cell 
populations either by class (T vs B) or by antigen 
specificity, is still a major problem (Miller et al, 1971s 
Wigzell & Andersson, 1971). The state of sensitization 
of T cells, their specificity and their function, can 
only be studied through assay of the effects they can 
mediate consequent to activation by specific antigens. 
Until a few years ago, the only available assay was the 
skin test -- either on an immunized animal or on the 
recipient of sensitized cells (adoptive transfer). The 
relatively recent development of a host of iri vitro 
assays has not, however, substantially improved certain 
aspects of the problem (Bloom & Glade, 1971; Revillard, 
1971). 
The assays themselves are difficult to perform 
and reproduce. Different assays are based on different 
effects mediated by antigen-activated lymphocytes, for 
example, inhibition of macrophage migration and cytolysis 
of target cells. Further, both in vivo and in vitro 
assays measure the total effect of a given cell popul¬ 
ation. It is possible that sub-populations of different 
I 
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composition and size mediate different effects and that 
the responses observed are not proportional to the 
number of sensitized cells specifically stimulated by 
antigen. Thus, at present, the results of the various 
assays can be compared only semi-quantitatively. Finally 
the assays reflect cell activation which is the functional 
effect of receptor binding of antigen; they do not 
directly measure the relative affinity of the "recognition 
site" for various antigens, which is a structural property 
of the system. These issues must be considered when 
evaluating investigations of receptor specificity. 
The earliest studies of the "immunological 
specificity of delayed hypersensitivity reactions to 
hapten-protein conjugates ... demonstrated the important 
contribution of the carrier protein ... " (Benacerraf 
& Levine, 1962; also Benacerraf & Gell, 1959a; Benacerraf 
& Gell, 1959b; Gell & Benacerraf, 1961). This was noted 
to contrast with the hapten specificity of the antibody 
response. The phenomenon of carrier specificity was soon 
examined using a remarkable diversity of carefully 
selected haptens, proteins, and conjugating procedures. 
The simplest in vivo system was used — skin testing 
of sensitized guinea pigs. The following relationships 
were clearly established. 
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(1) "Sensitized animals which gave strong delayed 
reactions to the immunizing conjugate cross- 
reacted poorly or not at all to (a) conjugates 
of the same hapten with a different carrier 
protein or (b) conjugates differing from the 
immunizing conjugate by having an £-amino- 
caproyl chain interposed between hapten and 
its attachment on the carrier protein. Animals 
sensitized with either lightly or heavily 
substituted conjugates exhibited strong 
delayed reactions to both conjugates, but 
more intense reactions to the immunizing 
conjugate were always observed" (Benacerraf 
& Levine, 1962). 
(2) Animals sensitized to a hapten conjugated 
to guinea pig serum albumin showed varying 
degrees of cross-reactivity to the same 
hapten conjugated to other mammalian serum 
albumins. Such serum albumins are known 
to exhibit serological cross-reactivity. The 
same hapten on completely unrelated proteins 
failed to cross-react, The homologous conjug¬ 
ate always elicited the largest reaction, while 
"the order of the extent of cross-reaction of 
the other serum albumin conjugates differed 
from one animal to another, possibly owing 
to individual variation ... It is also note¬ 
worthy that the non-ionic hapten p-nitro- 
benzoyl shows strikingly more carrier-specif¬ 
icity than the ionic m-azobenzenesulfonate" 
(Gell & Silverstein, 1962a). 
(3) "The specificity of the delayed hypersensitivity 
reaction is such that it can distinguish the 
type and position_/ of linkage by which a 
given hapten is attached to a given protein 
carrier. In no instance was a cross-reaction 
observed in any of the hapten-protein pairs 
among which the only difference was the site 
of attachment of hapten on the carrier protein 
surface" (Gell & Silverstein, 1962a). 
(4) An elaborate series of substituted azobenzene 
conjugates of guinea pig albumin were 
prepared, with the benzene ring containing 
various ionic and non-ionic groups in different 
positions. There was appreciable cross¬ 
reactivity between the hapten-protein pairs 
among which the only difference was the nature 
and/or position of the substituent on the 
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benzene ring of the hapten. The degree of cross- 
reactivity was clearly greater than exhibited 
by anti-hapten antibody. As always, the 
immunizing hapten-carrier conjugate elicited 
the maximal response (Silverstein & Gell, 1962b). 
Thus delayed hypersensitivity was shown to be not only 
"more specific with respect to the total function 
determinant, but less specific with respect to the small 
haptenic moiety" (Silverstein & Gell, 1962b). 
With the development of in. vitro assays, the 
specificity of cell-mediated immunity to hapten-protein 
conjugates has been carefully re-examined (Davie & 
Paul, 1970; Paul & Siskind, 1970; Paul, 1970; Rajewsky 
& Pohlit, 1971)* The "classic" findings cited above have 
been emphatically confirmed and a somewhat more precise 
quantification of the degree of cross-reactivity among 
the various conjugates has been achieved. Further, Francis 
and Paul, (1970) have used an in vitro assay to study the 
ability of a hapten (€-DNP-L-lysi ne) to inhibit the 
activation of sensitized cells by the immunizing conjugate 
(DNP-GPA). They concluded: 
"Inhibition can be demonstrated only when 
exceedingly small antigen concentrations 
(10“3ug/ml) and enormous molar ratios of hapten 
(lO4*) are used. 
These data suggest that cells involved in 
cellular immune responses possess receptors 
which can interact with haptenic determinants. 
The simple interaction of hapten with such 
receptors is, however, insufficient to stimulate 
such cells so that the specific stimulation 
of immunocompetent cells must involve other 
requirements". 
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Simple, reversible, structural interaction with the 
recognition site is clearly insufficient for functional 
activation of the receptor mechanism. 
Small peptides of known amino acid composition 
and sequence, such as polypeptide hormones, have also 
been used to investigate the specificity of delayed 
hypersensitivity. For example, the immunogenic capacity 
of the AGTH 1-24 peptide appears to reside in the 11-24 
fragment, much of it in the 17-24 octapeptide. Smaller 
peptides are clearly inactive. Comparison of antigenic 
fragments (eg. 11-24) with non-antigenic ones (e.g. 1-13) 
suggest that immunogenicity is a function of particular 
amino acid sequences rather than simply the presence of 
particular types of amino acids. The sequence of the 
peptide determines its conformation, which is, in turn, 
the basis of its immunologic activity (Savin & Liauw, 196?)» 
Another study using synthetic Angiotensin II 
(an octapeptide) demonstrated a close relationship between 
the immunogenicicity of a determinant and its capacity 
to elicit a delayed reaction. That is, (1) free angio¬ 
tensin and angiotensin-protein conjugates were immuno¬ 
genic and (2) in animals immunized with conjugates, both 
free angiotensin and heterologous conjugates could 
cause delayed reactions (Dietrich, 1966). Unfortunately 
there is no detailed data on the relation between 
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peptide sequence and conformation in these systems. 
The specificity of cell-mediated immunity to the 
DNP-oligo-lysine system has been exhaustively examined. 
The original in vivo studies showed that small non- 
immunogenic members of the homologous series of peptides 
elicited only antibody-mediated (Arthus) reactions. 
Larger, immunogenic members elicited both Arthus and 
delayed reactions. In particular, the upper limit of 
the antibody combining site corresponded to the smallest 
peptide which was immunogenic (Schlossman & Levine, 1967)* 
More recent in vivo work has demonstrated "the high 
degree of specificity possessed by the recognition 
mechanism associated with the lymphoid cells which 
mediate cellular immune responses" (Paul et al, 1971). 
In particular, 
"the sensitized cell is maximally stimulated 
by the homologous immunizing antigen and can 
discriminate among components which differ from 
one another only in the position of a 
dinitrophenyl group or D-lysine residue on 
an identical oligo-lysine backbone ... /it 
appears that/ the majority of cells produced 
as a consequence of immunization have stereo¬ 
specific antigen receptors for the DNP- 
oligo-lysine / i.e. the hapten-carrier 
conjugate_J used to induce the response; a 
smaller and more variably-sized population 
of cells is produced with receptors specific 
for the oligo-lysine portion / i.e. carrierJ 
of the immunizing antigen" (Schlossman et al, 1969). 
One of these studies found an imperfect correlation 
between the in vivo skin test and the in vitro assay. 
In particular, the assays indicated reactivity to some 
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antigens which had given negative skin tests. The 
pattern of these responses suggested the existence of 
a smaller, purely carrier-specific cell population, 
as mentioned above. The investigators commented only 
that "these observations suggest that the in vitro 
response as measured by thymidine incorporation is 
either a more sensitive assay, or alternatively, not a 
simple in vitro correlate of delayed hypersensitivity" 
(Schlossman et al, 1969). 
The studies considered thus far have focused on 
the specificity of delayed hypersensitivity at a given 
point in the immune response. There remains the important 
issue of whether, with time, delayed hypersensitivity 
exhibits a maturation of affinity and broadening of 
specificity analogous to the changes seen in the antibody 
response. The direct in vivo system is not well suited 
to approaching this question. The onset of antibody 
production causes the appearance of "immediate hyper¬ 
sensitivity" (the Arthus reaction) at the site of an 
intradermal challenge. As expected, this reaction is 
hapten-specific and it generally extends from about 
1 to 6 hours after the challenge. Its appearance 
complicates, at the very least, the reading and inter¬ 
pretation of the delayed reaction. In most in vivo 
studies, skin testing was performed 7-10 days after 
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immunization, at which time delayed hypersensitivity 
can be demonstrated but there is generally no Arthus 
reaction. This procedure avoids the problem but, 
unfortunately, begs the question. 
One investigation of this issue used the adoptive 
transfer system (Phair & Kantor, 1968), This work 
indicated that ’’the ability of donor cells to transfer 
delayed hypersensitivity persisted throughout the 
primary and secondary antibody responses of the donor 
animals. The skin reactions elicited in recipients of 
cells from hyperimmunized guinea pigs remained conjugate- 
specific throughout the immune response". 
Several studies have attempted to evaluate 
directly the course of the delayed hypersensitivity 
response in an actively sensitized animal (Henney, 1970; 
Kruger et al, 1971). These studies appear to indicate 
that after 2-3 weeks a hapten-specific component of 
the delayed reaction can be identified. This component 
was accented by challenge with higher doses of hapten 
on a heterologous carrier. In all cases the simultaneous 
presence of hapten-specific antibody was documented either 
by the Arthus reactions or serum binding activity. 
However, the conclusions reached in these studies 
have been challenged. Using passively and actively 
immunized guinea pigs, Phair and Kantor (1970) studied 
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the interaction of sensitized cells, immune serum and 
challenge antigen at various concentrations. Hapten- 
specific delayed reactions were produced in the recipients 
of sensitized cells by (1) challenge with a high concentr¬ 
ation of hapten conjugated to heterologous carrier 
protein; (2) simultaneous transfer of hyperimmune 
serum; (3) challenge at the site of an unrelated 
immediate reaction. In actively immunized guinea pigs, 
hapten-specific reactions were facilitated by preparation 
of the challenge site with anti-hapten antibody, normal 
serum, or unrelated immediate reactions. The investig¬ 
ators considered that two mechanisms might underlie such 
hapten-specific delayed reactions; 
" (1) increased retention of antigen at the 
skin site secondary to antigen-antibody 
interaction and consequent stimulation of 
those cells capable of responding to an 
increased concentration of hapten; (2) a 
non-specific increase in the number of 
mononuclear cells at the reaction site, 
thereby increasing the probability of 
interaction of antigen and cells with a 
high affinity for the haptenic group" 
(Phair & Kantor, 1970). 
The question of "maturation" of the specificity 
of delayed hypersensitivity has also been examined using 
an in vitro assay (Henney & Nordin, 1971). The results 
obtained will be considered in some detail, for they 
highlight both the potential and the problems of in 
vitro methodologies (Table II). The data for effector 

Table II 
Specificity of cytotoxic lymphocyte population from 
guinea pig spleen following immunization with 
DNP-HGG 
Time after 
Immunization 
^Specific -^Cr Release3, from Masto- 
cytoma cells Coupled with: 
DNP-HGG DNP-BSA HGG 
days 
4 4.1 0 0 
7 13.5 4.5 7.1 
14 31.3 20.0 28.6 
21 19.9 15.9 17.6 
28 18.7 10.1 15.9 
Or SI Cr release in the presence of lymphocytes 
from specifically immunized animals minus the 
release obtained in the presence of lymphocytes 
from unimmunized controls. 
1 
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cell activation by the immunizing conjugate confirm 
previous expectations. The authors comment that it was 
"rather unexpected" to find 
"that ’target’ cells bearing only the carrier 
portion of the immunizing conjugate were lysed 
as effectively as those bearing the whole 
conjugate". 
They used the macrophage migration inhibition test 
to provide additional evidence. Those results reassured 
them (Table III), Nevertheless, it is quite clear that 
the two assays give quantitatively different anwers, 
Moreover, although the workers make no comment on it, 
the degree of "hapten-specific" lysis (64$ of conjugate 
lysis on d.l4j 80$ on d.2l) is not only unexpected, but 
quite startling. The cause of these anomalies is 
uncertain. First, the stimulus is very complex. Random 
light conjugation of a population of carriers could 
easily produce overlapping sub-populations containing 
(l) each major carrier determinant intact and (2) the 
hapten in a wide variety of environments, Further, the 
in vitro assays probably are more sensitive than the 
in vivo test and can more readily detect small populations 
of cells responsive to pure carrier determinants or 
hapten-focused cross-reacting determinants. There are 
also probably "non-specific recruitment" effects. In 
addition, a variety of cell types are present in the 
lymphocyte pool assayed. For instance, the authors 

Table III 
A comparison between the specificity of the humoral 
and cell-mediated immune response of guinea pigs 
14 days following immunization with dinitro- 
phenylated human IgG 
DNP-HGG DNP-BSA HGG 
% cytol,ysisa 31.3 20.0 28 o 6 
% inhibition of 
macrophage mi- 
gration*3 
60 - 2.2 24 - 4.8 41 ± 2.8 
PFC/106 splenic 
lymphocytes0 930 789 6 
a ^specific release as per Table II 
10 The percent inhibition of the migration of 
peritoneal exudate cells from unimmunized 
guinea pigs in the presence of lymphocytes, 
from animals immunized with DNP-HGG, and 
300g/ml antigen. The values given are 
- standard error of the mean of nine 
determinants on a pooled lymphocyte 
preparation from three spleens. 
c Total ("direct” and "indirect") plaques per 
10° splenic lymphocytes using antigen-coated 
SRC. 
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clearly document cells producing hapten- and carrier- 
specific antibody, but do not control for any effect 
this might have. It must be stressed that this study 
is one of the most careful and precise available,* it is 
the state of the art that wants improving. 
One well-investigated system does seem to exhibit 
hapten-sepcific delayed hypersensitivity -- p-azobenzene- 
I 
arsonate (pABA) derivatives of tyrosine (Leskowitz, 1963; 
Leskowitz et al, 1966). Studies with these derivatives 
emphasise the relationship between the immunogenicity 
of a given molecular configuration and its capacity 
to evoke a delayed reaction. Animals immunized with 
pABA-N-acetyl-L-tyrosine amide (pA3A-tyr; molecular 
weight, 450), the smallest known Independent immunogen, 
will produce characteristic in vivo delayed reactions 
to homologous or heterologous conjugates of pABA 
(Leskowitz et al, 1966; Borek, Stupp & Sela, 1965)® 
In vitro, their lymphocytes can be activated by pABA-tyr 
or a protein conjugate with equal efficiency {Nauciel 
& Raynaud, 1971). Further, the immunogenicity of a 
variety of non- or weakly-immunogenic proteins and 
synthetic polypeptides is notably increased by conjugation 
with pABA. This change is accompanied by the development 
of hapten-specific delayed sensitivity,(Jones & Leskowitz, 
1965; Borek & Stupp, 1965; Stupp, Borek & Sela, 1966). 
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Of the azophenyl acids, only conjugates of 
phosphanilic acid (pABP) share this immunologic property; 
conjugates of aminobenzoic (pAB) or sulfanilic (pABS) 
acids clearly do not,(Leskowitz & Zak, 1966; Borek 
& Stupp, 1965). Substituted derivatives of pABA and 
pABP conjugates have been used to compare the cross - 
reactivity of hapten-specific delayed sensitivity with 
that of hapten-specific antibody. The results were 
interpreted as indicating that, in this system at least, 
"recognition sites for delayed sensitivity are very 
similar to those for antibody" (Leskowitz, 196?). 
Nevertheless, the mechanism of hapten-specific delayed 
hypersensitivity remains unclear. The simplest hypothesis 
is that this particular configuration of polar and 
hydrophobic groups can by itself provide sufficient 
interaction to activate the necessary and appropriate 
cells. That is, unlike other haptens, this moiety does 
not require the additional energy contribution of 
adjacent carrier determinants, 
Structural Aspects of the Receptor. 
The work reviewed to this point has concerned the 
specificity of delayed hypersensitivity and, therefore, 
the functional characteristics of the antigen receptors 
involved. There has also been a considerable effort to 
clarify the structural characteristics of T cell 
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receptors. Here too, there are a variety of methodo¬ 
logical problems. The lymphocyte populations most 
easily obtained contain more B cells than T cells. 
Moreover, B cells appear to bind much more antigen to 
their surface, and more readily. Therefore, techniques 
are required which specifically detect T cells or 
provide T cell enriched populations (Miller et al, 1971). 
Much of the work available is very recent and either 
unconfirmed or challenged. This survey will focus on 
those generalizations that seem most broadly supported. 
Multiple lines of evidence suggest that T cells 
do have specific antigen binding receptors: (1) the 
specific activation of T cells by antigen; (2) specific 
inactivation of T cells by 125i_xabelled antigen (antigen 
induced cell "suicide’'); (3) the capacity of T cells to 
carry memory and to be made tolerant (reviewed by Moller, 
1970; Dwyer & Mackay, 1971; Miller et al, 1971). It has 
been somewhat difficult to establish conclusively that 
there are antigen-binding structures actually on the 
cell surface. T cells seem to have far fewer such 
structures than B cells (Raff, 1970; Rabellino et al, 
1971; Unanue et al, 1971; Greaves & Hogg, 1971). The 
estimate is that there are in the order of 500 receptors 
on the surface of a T cell, but 50,000 - 150,000 on a 
B cell (Marchalonis et al, 1972). 
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Evidence is accumulating that the recognition 
structure is an immunoglobulins (1) Anti-light-chain 
antisera has been reported to inhibit the ability of 
lymphocytes to effect the graft vs host reaction of the 
transfer of delayed hypersensitivity (Greaves et al, 1969; 
Mason & Warner, 1970); (2) anti-kappa antisera has been 
shown to protect T cells against ^^I-antigen "suicide" 
(Basten et al, 1971); (3) anti-Fab and anti-light-chain 
antisera can inhibit T-rosette forming cells (Greaves & 
Hogg, 1971). 
The class of heavy chian is a matter of considerable 
debate. Many studies have found no evidence for any of 
the currently known class of heavy chain (reviewed by 
Greaves & Hogg, 1971). Recent data from Greaves and 
Hogg (1971) suggest that there are ju chains on T cells 
but perhaps only partially exposed. They support the 
interpretation that the differences between antigen 
receptors on T and B cells are both (1) quantitative, 
T cells having far fewer receptors, as noted above, 
and (2) qualitative, T cell receptors being "buried in 
the plasma membrane in such a way that only the variable 
region (containing the combining site) is exposed". 
Furthermore, speculating from studies of cells before 
and after challenge, they constructed a model of matur- 
ational changes in the relationship between the receptor 
. 
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and the cell surface membrane. In particular, they 
hypothesized increased exposure of the heavy (ji) chains 
after immunization. Other evidence for m chains in the 
receptor is based on the claim that immunoglobulin 
isolated from the surface of T cells contains heavy 
chain which resembled ;u--chain in electrophoretic 
behavior (Marchalonis et al, 1972), Both these studies 
are unconfirmed and involve new, specialized techniques; 
they are, therefore, difficult to analyze critically at 
this time. 
It must be stressed that the evidence associating 
the immunoglobulin detected on the cell surface with the 
putative receptor is subject to several important 
limitations. First, there is no unequivocal evidence 
that the cell has synthesized the immunoglobulin. However, 
there have been several attempts to coat lymphoid cells 
with "exogenous" antibody using a variety of in vivo 
and in vitro conditions and none have produced any 
significant passive absorption (Greaves, 1971). Second, 
the inhibition of receptor function by anti-light-chain 
or anti-Fab antisera may result from (a) the receptor 
site actually containing the immunoglobulin determinant 
or (b) the receptor site being in closer proximity to 
the determinant and the binding of antisera interfering 
with the receptor by steric hindrance. Moreover, the 
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techniques currently stressed cannot clarify antigen¬ 
binding specificities and affinities of the recognition 
site nor elucidate the mechanism by which antigen-binding 
activates the cell. 
Some Hypotheses about the Receptor. 
Extrapolating from the wide variety of data that 
has been presented, it is possible to formulate several 
hypotheses about the antigen-binding structure of cell- 
mediated immunity. This may facilitate considering 
methods for further study. (For convenience, "receptor" 
will be used when referring to the antigen-binding 
structure, which is the first component of the functional 
receptor). 
(1) The receptor is an immunoglobulin. 
This will only be established when the receptor is 
actually isolated. The class of heavy chain is of little 
concern for this model. It would not, however, be 
surprising if a new class were found. The Fc region of 
a cell-associated receptor could reasonably have a different 
structure for its special function. 
(2) The receptor site is the same size as an immunoglobulin 
combining site. 
(3) An "effective determinant" is one which can specifically 
elicit a cell-mediated immune reaction. It is generally 
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about the size of the receptor site. 
As has been seen, the volume of the combining site is 
considerably larger than most simple haptens and can 
encompass significant portions of most of the globular 
proteins commonly used as carriers. Data from several 
systems shows that (a) the minimum size for an immunogen 
is approximately the upper limit of the antibody combining 
site and (b) the requirements (including size) for 
immunogenicity are closely related to those for eliciting 
a delayed reaction. Further, there is evidence that 
an antibody combining site may have several "contact 
regions" each with a different "specificity" (Rosenstein 
et al, 1972). Presumably, therefore, a site-filling 
antigen would bind to the site at more than one point. 
As a result of such multiple contacts, it might be 
expected that (a) the affinity of the site for the antigen 
would be relatively great (in the antibody systems consid- 
6 9 -1 
ered above K0's of about 10 to 107(M/L) are generally 
found), (b) altering any single determinant (eg.hapten) 
would not greatly affect the overall interaction of the 
antigen and the site unless marked steric hindrance 
was introduced and (c) the relative configuration of the 
various contact determinants (i.e. the structure of the 
antigen) would be of central importance to the overall 
interaction. These characteristics anticipated of a site¬ 
filling determinant are congruent with the phenomena of 
0 
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carrier specificity. 
(4) As carrier specificity is both sufficient and 
necessary in cell-mediated immunity, such site¬ 
filling is a requirement for activation of the cell. 
One can only speculate about the mechanism of such a 
receptor. It might reasonably be offered that the inter¬ 
action of antigen and receptor causes a conformational 
change in the receptor which leads to cell activation. 
Metzger (1970) has reviewed the work that might provide 
data to support such a suggestion. He concluded: 
"So far, no convincing evidence is at hand 
which demonstrates that reactions at the 
combining sites of antibody produce defined 
conformational changes elsewhere in the 
molecule". 
It could be argued that the environment of the cell 
receptor facilitated changes not noticeable in other 
contexts. Moreover, the systems studied have primarily 
involved either highly heterogeneous antibody populations 
against a hapten-protein conjugate, or myeloma proteins 
with anti-hapten binding activity (Ashman et al, 1971). 
The next logical system to examine would seem to be the 
structured site-filling antigens which elicit antibody 
populations of restricted heterogeneity. 
The model suggests an explanation for why some 
"structure" — a "preferred conformation" — seems to 
be a requirement for immunogenicity. The process of 
inducing a conformational change in the receptor requires 
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energy. One source for this energy might be the potential 
energy inherent in a preferred structural configuration 
of the antigenic determinant. However, with increasing 
rigidity, the antigen could presumably fit into fewer 
receptor sites. This may explain such situations as the 
(DNP)2“gramicidin-S system where only one clone was 
stimulated in some animals, and apparently none in others. 
Exceptions to the site-filling structured antigen 
hypothesis can be accommodated by the model by presuming 
that they can satisfy in other ways the requirements 
for energy of interaction with the receptor. For example, 
the "hapten-specific" delayed hypersensitivity of the 
pABA system may represent a situation where an ordered 
arrangement of strong polar and hydrophobic groups can 
interact sufficiently with particular points around the 
receptor combining site to cause activation. Finally, 
it should be noted that this model is not intended to 
apply equally to the interactions of antigens and 
antibody-producing cells. While there is evidence that 
these hypotheses might be relevant to some aspects of 
that system, different mechanisms may operate in 
other aspects. 
Methods for the Study of the Receptor. 
More direct and controlled methods are required 
to characterize further the structure and function of the 
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receptor and, ultimately, to isolate it from the cell. 
"Affinity labelling" is a technique which has been very 
successfully used in the study of the antibody combining 
site (Singer & Doolittle, 1966; Singer, 1967). The method 
depends upon the ability of a bifunctional reagent to 
(l) combine specifically with the particular anti¬ 
body and (2) react readily with amino acid residues to 
form covalent bonds. The successful labelling of the 
receptor recognition site should block the ability of 
the cell to respond to antigen. This functional effect 
could be evaluated with an in vitro assay or an adoptive 
transfer. Necessary controls would include (l) persistence 
of sensitivity to an unrelated antigen to evaluate non¬ 
specific toxic effects of the procedure and (2) "cross¬ 
over" experiments using labels derived from two unrelated 
determinants to evaluate effects due to possible differ¬ 
ences in the numbers and types of sensitized cells elicited 
by different antigens. Further, a radioactive tag on 
the affinity label would permit the use of autoradiography 
to localize the site of the receptor, and would provide 
a means of tracing the labelled recognition structure 
through physico-chemical procedures leading to its 
isolation and structural characterization. In these 
experiments it would be necessary to evaluate the 
specificity with which the label attached to the receptor 
as opposed to elsewhere on the cell. This might be done 
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by protection and differential labelling techniques 
(Singer, 196?). 
Affinity labelling of receptors on antibody- 
producing cells has been attempted and is fraught with 
problems, Plotz (1969) and Segal et al (1969) independ¬ 
ently reported the specific inhibition of antibody response 
using affinity labels derived from hapten. This work is 
often cited, but not confirmed and apparently not 
reproducible, Naor et al (1970) demonstrated that such 
systems are plagued by many effects not related to the 
reaction of the label with the receptor. Moreover, they 
concluded that the percentage of specifically sensitized 
cells in a normal lymphocyte population was so small and 
the fraction of specific receptor to cell membrane so 
tiny that "the cumulative level of nonspecific modific¬ 
ations in the system almost certainly would nullify 
specific approaches to isolating few affinity labelled 
receptors". 
In cellular immune systems, the difficulties of 
affinity labelling are compounded, Kantor (1969) was 
unsuccessful in attempts to use Segal's affinity labels 
to block the transfer of delayed hypersensitivity even 
though the treated cells were heavily conjugated. In 
contrast, Hill (1971) claimed that an affinity label 
derived from the same hapten could block an adoptive 
transfer and could permit the isolation of a putative 
receptor. 
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The immunizing agent Hill used was l-Fluoro-2»4- 
dinitrobenzene (FDNB) (I in Fig. 1), which is known to 
react with the free amino groups of lysines of skin 
proteins to yield £ -2,4-d.lnitrophenyl lysine (£-DNP- 
lysine) residues (II). It is probably by thus altering 
autologous proteins that FDNB causes contact sensitivity. 
Sensitization with FDNB or DNP-protein conjugates also 
effectively elicits anti-DNP antibodies. The binding 
sites of these antibodies have been extensively invest¬ 
igated with a series of affinity labels, the most success¬ 
ful being m-nitrobenzenediazonium fluoroborate (MNBDF) 
(III) (Good, Traylor & Singer, 196?). 
Hill sought to derive from 6-DNP-lysine a new 
affinity label which would "resemble the DNP-protein 
conjugate more closely". He reports the synthesis of 
£-2-nitro-4-aminophenyl lysine (6-NAP-lysine) (IV) and 
its conversion to £-2-nitro-4-diazophenyl lysine (6-NDP- 
lysine). He further claims that the precipitation of 
anti-DNP antibody by DNP-albumin was blocked reversibly 
by £-NAP-lysine and irreversibly by the affinity label. 
No data is presented to support these assertions. Previous 
investigation of hapten-antibody binding in the DNP 
system seemed to indicate that reduction of a nitro 
group, particularly the "lead" or "4" group, would 
significantly lower the affinity of the combining site 
for the altered hapten (Pressman & Grossberg, 1968), 
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Our attempts to reproduce Hill's work strongly indicated 
that this was the case and, threfore, affinity labelling 
of cells with this system was not attempted. 
The work of Francis and Paul (1971) and of 
Kantor (1969) suggests that most hapten-derived affinity 
labels will be ineffective because of insufficient 
ability to localize at the receptor. Rather, an affinity 
label for the recognition site of delayed hypersensitivity 
should be based on an "effective determinant". In part¬ 
icular, it would be desirable to have a small, defined, 
readily synthesized determinant to which the reactive 
labelling group could be easily attached; possibilities 
include immunogenic DNP-oligo-lysines, hormone peptide 
fragments, or pARA derivatives. Another model might be 
the defined sequence antigen of widely spaced £-DNP- 
lysines on an alanine backbone (Richards et al, 196?). 
This polypeptide readily elicited the production of anti- 
DNP antibody in rabbits, but would not elicit delayed 
hypersensitivity in guinea pigs (Leskowitz, 196?). There 
are many advantages to using a peptide polymer of this 
type as an immunogen. Those discussed by Richards et al 
include simplicity, homogeneity and conformation. With 
respect to the current issue, the monomer or a similar 
sub-unit of the peptide might serve as the basis for an 
affinity label. In addition, controlled variations 
could be readily made for use in studying the specificity 
of the receptor (as per Parker et al, 1966). 
I 
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The task thus became to establish the minimal 
modification necessary to make the above peptide 
immunogenic to guinea pigs. The requirements for immune- 
genicity of synthetic peptide antigens in terms of 
complexity of amino acid composition and sequence have 
been partially but not systematically studied (Sela, 1966; 
Borek, 1968; Rude, 1970). On the basis of available 
reports it was felt that the addition of approximately 
two tyrosine residues among the ten alanine residues 
might be sufficient. There were also advantages to 
adding tyrosine — (1) it could serve as the point of 
attachment of other haptenic groups, in particular, the 
azophenyl acids; (2) it could be radioactively tagged 
at very high specific activity with ^5i for a variety 
of studies. Unfortunately the synthesis of the desired 
polymer was not achieved due to time limitations and, 
therefore, no definite conclusions about its immuno- 
genicity can be made. As detailed above, the monomeric 
units which were synthesized were non-immunogenic. 
Summary. 
Cell-mediated immunity encompasses many immuno¬ 
logical phenomena including homograft and tumor 
rejection. The operative immunocompetent cells appear 
to be stimulated by the specific interaction of 
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antigen with surface membrane associated receptors. 
Evidence concerning the functional and structural 
characteristics of these receptors has been reviewed. 
Further study of them through an affinity label based 
on a defined peptide antigen has been considered. The 
molecular mechanism of the specific activation of 
immune cells is at present unclear, and a variety of 
methodological approaches will be necessary to further 
our understanding of antigen receptors. 

Appendix 
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Details of Peptide Synthesis. 
Four different procedures were used in the attempt 
to synthesize the desired peptide. The conditions which 
were varied included the initiator, the solvent for 
the initiator, the amounts of NCAs and the reaction time. 
The products were coded as follows; SAM-4A means 
Synthetic Antigen Model -• procedure #4 ~ peak A. 
Table AI compares the conditions of the various 
procedures. Figures Al, A2 and A3 show the gel 
chromatographic separation of the products of reaction 
and give the average peptide composition for the 
analy z ed p eaks , 
Several observations may be made relating the 
various reaction conditions with the products obtained. 
First, initiation with £-DNP-L-lysine HC1 gave a very 
heterogeneous collection of products even when it was 
relatively well dissolved. We assumed that this reflected 
the tendency of the initiator amine to be protonated. 
Since only the free base can initiate NCA polymerization, 
different subsets of the initiator pool activated the 
NCAs at different times. This led to the formation of 
populations of different size peptides as reflected in 
the multiple peaks. Thus, it appeared necessary to prepare 
an initiator with an unproponated amino group. It should 
be noted that although SAM-2E had the desired composition, 
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its yield was so small and its homogeneity seemed 
so improbable that the procedure was not acceptable. 
Initiation with the free base ethyl ester was 
much more satisfactory. Procedure 3 contained anomolous 
peaks of high tyrosine:DNP content because of technical 
errors in preparing the NCA reaction mixture. These led 
to the premature decomposition of some NCA-tyrosine and 
thus the presence of peptides initiated by tyrosine 
instead of DNP-lysine. Procedure 4 was almost ideal. 
Virtually all the product was found in a single, large, 
apparently homogeneous peak whose composition closely 
reflected that of the starting materials. The few small 
trailing peaks presumably reflect delayed initiation 
by the initially insoluble portion of initiator. With 
some additional experimentation, conditions might be 
found which give a reaction product of uniform compo¬ 
sition, By thus eliminating the multiple purification 
steps, sufficiently high yields might be obtained to 
achieve successful polymerization of the peptide. 
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Figure A1 
SAM-1 s Gel Chromatography Fractionation 
0^360 — Tube number 
Conditions: P-2 Bio Gel column (2.5cm x 77cm) eluted 
with PBS. Each tube represents 9»9niin 
collection (approximately 4.6ml). 
Results : By amino acid analyzer 
Peak (Tubes) Average Composition 
(D,L-ala:L-tyr:6-DNP-L-lys) 
SAM-1A (61-70) 2.7 J 1 : 1 



Figure A2 
SAM-2 : Gel Chromatography Fractionation 
OD^q vs. Tube number 
Conditions : as for SAM-1 
Results : By amino acid analyzer 
Peak (Tubes) Average Composition 
(D,L-ala:L-tyri£-DNP-L-lys) 
SAM-2A (29-31) 
SAM-2E (53-60) 
43 : 4.8 : 1 
10.8 : 2.3 : 1 
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Figure A3 
SAM-3 J Gel Chromatography Fractionation 
OD360 and- ^^278 — num^er 
Conditions : as for SAM-4 
Results : By spectrophotometric analysis 
Peak (Tubes) Average Composition 
(D,L-ala:L-tyr:£-DNP-L-lys) 
SAM-3A (41-66) 17.4 : 4 : 1 
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